- Previous Close
96.80 - Open
95.96 - Bid --
- Ask --
- Day's Range
95.59 - 96.38 - 52 Week Range
77.54 - 101.10 - Volume
2,428,802 - Avg. Volume
1,451,562 - Market Cap (intraday)
47.369B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
46.72 - EPS (TTM)
2.05 - Earnings Date May 13, 2025
- Forward Dividend & Yield 0.27 (0.28%)
- Ex-Dividend Date May 14, 2024
- 1y Target Est
106.09
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
www.alcon.com25,599
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ALC
View MorePerformance Overview: ALC
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALC
View MoreValuation Measures
Market Cap
47.35B
Enterprise Value
50.65B
Trailing P/E
46.72
Forward P/E
29.67
PEG Ratio (5yr expected)
3.06
Price/Sales (ttm)
4.81
Price/Book (mrq)
2.20
Enterprise Value/Revenue
5.11
Enterprise Value/EBITDA
18.93
Financial Highlights
Profitability and Income Statement
Profit Margin
10.27%
Return on Assets (ttm)
2.85%
Return on Equity (ttm)
4.83%
Revenue (ttm)
9.91B
Net Income Avi to Common (ttm)
1.02B
Diluted EPS (ttm)
2.05
Balance Sheet and Cash Flow
Total Cash (mrq)
1.84B
Total Debt/Equity (mrq)
23.85%
Levered Free Cash Flow (ttm)
1.35B